← Human Trials & Peer-Reviewed Studies
Serum 25-hydroxyvitamin D response to vitamin D supplementation using different lipid delivery systems in middle-aged and older adults: a randomised controlled trial.
Plain-language guide to PMID 36912075 (2023): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 20 adults.
Key Facts
- PMID
- 36912075
- Journal
- The British journal of nutrition
- Year
- 2023
- Study type
- Randomized Controlled Trial
- Authors
- McCourt AF et al. (5 authors)
- DOI
- 10.1017/S0007114523000636
What This Study Did, in Plain Language
What Was Tested
Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.
This randomised, placebo-controlled trial examined the effect of the lipid composition of a vitamin D-fortified dairy drink on change in 25-hydroxyvitamin D (25(OH)D) concentrations.
Serum was collected at baseline and post-intervention to measure 25(OH)D concentrations and biomarkers of metabolic health.
Who Took Part
According to the abstract, 20 adults were involved.
The age groups tagged for this paper are middle-aged adults and older adults.
How the Study Was Run
The researchers set it up as a randomized and placebo-controlled study.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.
What Was Measured
Serum was collected at baseline and post-intervention to measure 25(OH)D concentrations and biomarkers of metabolic health.
Repeated-measures general linear model ANCOVA (RM GLM ANCOVA) compared changes over time.
PubMed files the paper under topics including Coconut Oil, Vitamin D, Calcifediol, Cholecalciferol, Vitamins, Dietary Supplements and Vitamin D Deficiency.
The authors tagged it with the keywords 25-hydroxyvitamin D, Food fortification, Older adults and Vitamin D deficient.
What This Means in Plain Language
The paper is a randomized and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 20 adults.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The publication is from 2023 (The British journal of nutrition), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.